Target General Information
Target ID T75476
Target Name Myeloid differentiation primary response protein (MyD88)
Gene Name MYD88
Species Homo sapiens
UniProt ID MYD88_HUMAN
Sequence MAAGGPGAGSAAPVSSTSSLPLAALNMRVRRRLSLFLNVRTQVAADWTALAEEMDFEYLE
IRQLETQADPTGRLLDAWQGRPGASVGRLLELLTKLGRDDVLLELGPSIEEDCQKYILKQ
QQEEAEKPLQVAAVDSSVPRTAELAGITTLDDPLGHMPERFDAFICYCPSDIQFVQEMIR
QLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFA
LSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLP [Ho
mo sapiens]
Drug and Corresponding Resistance Mutations
Mutation Info Missense: L265P
Drugs
Drug Name Ibrutinib Drug Info [1]
Targeted Disease Refractory hematologic malignancy
Mutation Prevalence 39% of the patients
References
REF 1 Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma. Br J Haematol. 2015 Aug;170(4):445-56.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.